About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Efficacy of Zoledronic Acid in Osteoporosis

NCT03183557·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Yukio Nakamura, MD, PhD
CONTACT
+81-263-37-2659 yxn14@aol.jp

Lead

Shinshu University

Age

20–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Osteoporotic patients who want to take zoledronic acid

You may not be if

Patients who are allergic to zoledronic acid or vitamin D
Patients who are pregnant or breast-feeding
Patients who have not taken zoledronic acid for the last 2 years

The record

StatusUnknown

PhasePhase 2

Taking part100

StartedOct 2017

UpdatedSep 21, 2021

Conditions

Where1

Yukio Nakamura
Matsumoto, Nagano, Japan

Clareo Health | Efficacy of Zoledronic Acid in Osteoporosis